University of Rochester School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center, Rochester, NY, USA.
Am J Rhinol Allergy. 2022 Jul;36(4):529-538. doi: 10.1177/19458924221081235. Epub 2022 Feb 23.
Chronic rhinosinusitis (CRS) is a common condition that affects patients' quality of life. Standard treatments for CRS have known side effects and variable efficacy rates. Thus, complementary and integrative (CIM) treatments for CRS such as crenotherapy, which utilizes high mineral content water or vapor as an inhalation therapy, are of continued interest.
To summarize and evaluate the current research investigating crenotherapy's therapeutic potential and clinical outcomes for the treatment of CRS.
Systematic review and qualitative analysis.
A systematic review was performed, with a comprehensive search strategy applied to 6 databases from inception to March 2021: CINAHL, Cochrane, Embase, PubMed, Scopus, and Web of Science. Studies with at least 10 patients, which investigated crenotherapy as the sole or adjunctive treatment for CRS in humans were included.
In total, 10 articles out of 756 were included. Of these, 6 were randomized controlled trials. The remaining four articles were non-randomized prospective cohort studies. Six studies assessed clinical symptoms in response to crenotherapy, and there were unanimous improvements in Visual Analog Scale (VAS), Sino-Nasal Outcome Test-20 (SNOT-20), and other quality of life metrics. The studies that assessed inflammatory markers, cytology, or other measures showed significant improvement in neutrophil count, spores, ciliary motility, IgE, and manometry. Minimal to no adverse events were reported across all 10 studies.
There is limited data to support crenotherapy's effectiveness in treating patients with CRS. However, published studies suggest that for certain patients crenotherapy can both improve CRS symptoms and objective measures of nasociliary function with minimal side effects. Findings must be interpreted with caution due to study heterogeneity, inconsistent use of standard CRS definitions and outcomes measures, as well as other study design flaws. Given these results, as well as a growing interest in CIM, crenotherapy treatments for CRS deserve further investigation.
慢性鼻-鼻窦炎(CRS)是一种常见的疾病,会影响患者的生活质量。CRS 的标准治疗方法有已知的副作用和可变的疗效。因此,对于 CRS 的补充和综合(CIM)治疗方法,如盐疗,利用高矿物质含量的水或蒸汽作为吸入疗法,仍然具有持续的兴趣。
总结和评估目前关于盐疗治疗 CRS 的潜在疗效和临床结果的研究。
系统回顾和定性分析。
进行了系统回顾,采用全面的搜索策略,从开始到 2021 年 3 月,在 6 个数据库中进行搜索:CINAHL、Cochrane、Embase、PubMed、Scopus 和 Web of Science。纳入了至少有 10 名患者的研究,这些研究调查了盐疗作为单独或辅助治疗 CRS 的人类。
在总共 756 篇文章中,有 10 篇文章被纳入。其中 6 篇是随机对照试验。其余 4 篇文章是非随机前瞻性队列研究。6 项研究评估了盐疗对临床症状的反应,视觉模拟量表(VAS)、鼻-鼻窦炎生活质量量表 20 项(SNOT-20)和其他生活质量指标均有一致改善。评估炎症标志物、细胞学或其他测量的研究显示,中性粒细胞计数、孢子、纤毛运动、IgE 和测压计有显著改善。所有 10 项研究均报告了最小至无不良反应。
目前的数据有限,不足以支持盐疗治疗 CRS 患者的有效性。然而,已发表的研究表明,对于某些患者,盐疗既能改善 CRS 症状,又能改善鼻-黏膜功能的客观指标,且副作用最小。由于研究异质性、对 CRS 标准定义和结果测量的不一致使用,以及其他研究设计缺陷,必须谨慎解释这些发现。考虑到这些结果以及对 CIM 的日益关注,CRS 的盐疗治疗值得进一步研究。